In the DLBCL group, 59 patients were treated with R‐CHOP, while other five patients with R‐CHOP‐like (three patients with R-DA-EPOCH, one patient with R-CDOP and one patient with R-GCVP) therapy. The gene discussed is DDIT3; the disease is diffuse large B-cell lymphoma.